tiprankstipranks
Trending News
More News >
INNOVATE Corp (VATE)
NYSE:VATE
US Market
Advertisement

INNOVATE Corp (VATE) Earnings Dates, Call Summary & Reports

Compare
266 Followers

Earnings Data

Report Date
Oct 30, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
Last Year’s EPS
-1.18
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 05, 2025|
% Change Since: -21.01%|
Earnings Call Sentiment|Negative
The earnings call highlighted strong performance and growth in the Life Sciences segment and successful debt refinancing transactions. However, these positives were overshadowed by significant declines in consolidated revenue and adjusted EBITDA, large net losses, and challenges in the Infrastructure and Spectrum segments.
Company Guidance -
Q3 2025
During INNOVATE Corp.'s second quarter 2025 earnings call, the company reported consolidated revenues of $242 million and adjusted EBITDA of $15.7 million, marking a decrease from the previous year due primarily to declines in the Infrastructure segment. DBM Global, a part of this segment, achieved revenues of $233.1 million with gross margin compression of approximately 230 basis points to 17.9% and adjusted EBITDA margin compression of 240 basis points to 8.3%. Despite these challenges, DBM's backlog increased by $300 million year-over-year to over $1.3 billion. In the Life Sciences segment, revenue surged by 88.2% to $3.2 million, driven by strong performance from R2 technologies. Meanwhile, the Spectrum segment faced a $500,000 revenue decrease to $5.7 million. The company also completed refinancing transactions, reducing its total outstanding indebtedness to $641.3 million. Additionally, the call highlighted strategic advances in various business areas, including MediBeacon's regulatory progress in China and the expansion of R2's Glacial Skin products.
DBM Global Backlog Increase
DBM Global's adjusted backlog increased by approximately $300 million year-over-year to just over $1.3 billion, with an additional $400 million project expected to be added in the third quarter.
Life Sciences Revenue Surge
Life Sciences revenue increased by 88.2% to $3.2 million, driven by R2's increased Glacial Spa unit sales and consumable sales both inside and outside North America.
R2 Growth and Market Potential
R2's top line revenue increased to $3.2 million from $1.7 million in the previous year. Patient treatments grew by 115.1%, and average monthly utilization per provider increased by 28.5%. Social media engagements outperformed competitors by 823%.
Debt Refinancing Transactions
INNOVATE completed a series of refinancing transactions, reducing outstanding indebtedness by $27 million and extending debt maturities, enabling the continuation of strategic plans.

INNOVATE Corp (VATE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

VATE Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 30, 2025
2025 (Q3)
- / -
-1.18
Aug 05, 2025
2025 (Q2)
- / -1.67
0.977-271.24% (-2.65)
May 06, 2025
2025 (Q1)
- / -1.89
-2.24915.96% (+0.36)
Mar 31, 2025
2024 (Q4)
- / -1.89
-2.24915.92% (+0.36)
Nov 06, 2024
2024 (Q3)
- / -1.18
-0.924-27.71% (-0.26)
Aug 07, 2024
2024 (Q2)
- / 0.98
-1.338173.02% (+2.31)
May 07, 2024
2024 (Q1)
- / -2.25
-1.303-72.60% (-0.95)
Mar 04, 2024
2023 (Q4)
- / -1.21
-0.896-35.49% (-0.32)
Nov 09, 2023
2023 (Q3)
- / -0.92
-0.844-9.48% (-0.08)
Aug 09, 2023
2023 (Q2)
- / -1.34
-1.74223.19% (+0.40)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

VATE Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 05, 2025
$5.76$5.68-1.39%
May 06, 2025
$6.24$6.15-1.44%
Mar 31, 2025
$7.83$7.31-6.64%
Nov 06, 2024
$5.14$5.16+0.39%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does INNOVATE Corp (VATE) report earnings?
INNOVATE Corp (VATE) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
    What is INNOVATE Corp (VATE) earnings time?
    INNOVATE Corp (VATE) earnings time is at Oct 30, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is VATE EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis